Great. Thanks, everyone, for joining. My name is Scott Schoenhaus. I am the health care tech equity analyst here at KeyBanc. We're a pleasure to have Ben Taylor, CFO of Recursion for a fireside chat.
Forbes contributors publish independent expert analyses and insights. John Sviokla covers GenAI/AI's impact on commerce and society. This voice experience is generated by AI. Learn more. This voice ...
With our introduction to the universe taking place hundreds of years after the canonical beginning of the overall Dead Space timeline, there are many concepts in the original Dead Space and its 2023 ...
Warning: this article contains full spoilers for Marvel's Spider-Man 2! Marvel’s Spider-Man 2 has finally landed on PC, and it gives superhero fans on a new platform the chance to have the same wild ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...